CD8A and neoplasm: This defect leads to the accumulation of insertions and deletions in DNA repeat sequences (microsatellites), that ultimately result in high tumor mutational burden (TMB), and to a high density of CD8+ tumor infiltrating lymphocytes, that are required for response to immunotherapy (23).